Conference 04/27/2022

  • Anticoagulation in VTE (Dr. Daugherty, PharmD)
    • Heparin à no renal metabolism (helpful in patients with renal failure)
      • Thrombocytopenia, HIT, heparin resistance, hyperkalemia from aldosterone suppression
      • Half-life 30-60 minutes, immediate onset
      • IV administration for VTE, must be administered inpatient
      • Careful monitoring required
    • Enoxaparin (Lovenox, LMWH)
      • Derived from heparin
      • 3-5 hour onset, no monitoring required, patients may self-administer 
      • Similar outcomes compared to heparin with regards to recurrent VTEs, some data suggest lower bleeding risk
      • Renal clearance, avoid in renal dysfunction 
      • Similar precautions as heparin
      • Lower incidence of HIT, but still contraindicated in patients with HIT
      • Subcutaneous dose for VTE
    • Apixaban (Eliquis)
      • Factor Xa inhibitor
      • Half-life 9-14 hours, BID dosing
      • Renal clearance, caution in renal insufficiency
    • Rivaroxaban (Xarelto)
      • Factor Xa inhibitor
      • Half-life 5-19 hours, daily dosing
      • Must be taken with food to be effective
      • Renal clearance, caution in renal insufficiency
    • Dabigatran (Pradaxa)
      • Direct thrombin inhibitor
      • Half-life 12-14 hours
      • VTE dosing after 5 days of bridging, BID dosing
    • 2020 AHS Guidelines on Management of VTE suggests using DOACs over Warfarin
      • Does not apply to all patients
      • AMPLIFY à Eliquis non-inferior to standard therapy (Warfarin, LMWH), less bleeding complications
      • EINSTEIN DVT/PE à Xarelto non-inferior to standard therapy
      • Does not recommend one DOAC vs. another, recommend using patient specific factors to guide clinical decision making
      • Recommends home treatment for patients with uncomplicated DVT
      • 2020 AHS guidelines recommend considering home treatment for patients with low-risk PE (PESI Score risk stratification), conditional recommendation
    • Extremely important to counsel patients when being discharged on these high-risk medications, ensue follow-up and understanding of risks and return precautions
  • Pneumomediastinum (Dr. Alia)
    • Presence of free air in the mediastinum
    • Spontaneous (idiopathic, tobacco use, recreational drug use) vs. secondary (i.e. traumatic, iatrogenic) etiologies
    • 30% have normal chest x-rays à CT Chest is preferred diagnostic modality
      • “Continuous diaphragm sign” on XR
    • Management:
      • Treat underlying cause
      • Supportive care à typically resolves spontaneously in 1-2 weeks
    • Disposition:
      • Primary à discharge with PCP follow-up
      • Secondary à management of underlying cause, typically will require admission
  • Lung Abscess, Parapneumonic Effusion, Empyema or (Dr. Edwards)
    • Typically polymicrobial, affected tissue at risk for necrosis and cavitation
    • Diagnosed via CXR vs. CT Chest (also recommended following XR diagnosis)
      • Ultrasound helpful for evaluation of effusions and for procedure guidance
    • Obtain blood and sputum cultures (blood cultures frequently negative in empyema)
    • Treatment à empiric antibiotics with anaerobic coverage
      • Empyema, effusions require drainage
      • VATS for complicated effusions and empyema
    • Thoracentesis provides definitive diagnosis for empyema (distinguishes between effusion and empyema) à body fluid cultures and diagnostics must be obtained
  • Pneumonia for EM Residents (Dr. Eisenstat)
    • CAP à everything not HAP or VAP
    • HAP à >48 hours from time of admission, previous admission within 90 days
      • Cover for pseudomonas and MRSA
    • VAP à >48 of intubation time, recent previous intubation  
      • Cover for pseudomonas and MRSA
    • Therapy tailored based on sensitivities and culture results
    • Normal vital signs and normal respiratory examination have good negative predictive value in most patients
    • Procalcitonin à good predictor of blood culture positivity
    • Hypoglycemia, lactate à predictors of 28-30 day mortality
    • 2-view chest XR recommended
    • Flu test patients with CAP during flu season
    • Give antibiotics to all patients clinically suspected to have CAP regardless of procalcitonin
    • Clinical judgement + decision tool is best (PSI > CURB-65)
    • Healthy, outpatient à amoxicillin vs. doxycycline vs. macrolide (if local resistance is <25%)
    • Comorbidities, outpatient à Augmentin vs. cephalosporin (cefpodoxime, cefuroxime) AND macrolide vs. doxycycline
      • Monotherapy with respiratory fluoroquinolone also acceptable, but consider risk factors
    • Inpatient treatment of CAP in adults without risk factors for MRSA or Pseudomonas
      • Combination therapy with Beta-lactam + macrolide or doxycycline
      • Monotherapy with respiratory fluoroquinolone
    • Inpatient treatment of severe CAP
      • Beta-lactam + macrolide (ex. Rocephin + azithromycin)
      • Beta-lactam + respiratory fluoroquinolone
    • Coverage of anaerobic pathogens not necessary in admitted patients who are suspected to have aspiration PNA
    • Inpatient treatment of patients with risk factors for MRSA and Pseudomonas à vancomycin or linezolid for MRSA, Zosyn/cefepime/meropenem for Pseudomonas
    • Corticosteroids are unnecessary unless used in patients persistently hypotensive despite IVF and vasopressors (i.e. surviving sepsis guidelines) but evidence is not conclusive
    • Give Tamiflu to patients with CPA who test positive for flu (regardless of inpatient vs. outpatient or duration of symptoms), give antibiotics regardless of flu positivity
    • Antibiotic treatment duration for outpatient treatment of CAP à 5-7 days
    • No follow-up CXR necessary in adults who are improving following treatment

Conference 04/13

  • Pediatric Respiratory Distress (Dr. Poteh)
    • Bronchiolitis
      • <2 years (>2 years is referred to as WARI)
      • Leading cause of hospitalization in infants in the US
      • Symptoms often worsen on day 3-5 of illness and worse at night
      • Hypoxemia occurs from V/Q mismatch from mucus plugging
      • Pathophysiology à infection causes inflammation of the bronchiolar epithelium
      • Commonly causes by RSV, but also caused by other viruses and bacterial infections
      • Exam tricks:
        • Expose trunk
        • Count RR yourself for at least 30 seconds
        • Note signs of respiratory distress
        • Assess activity level (playful, fatigue, lethargic)
        • Assess hydration status (tears, saliva, capillary refill, wet diapers in 24 hours)
        • Check the ears (occasionally have coinfections)
        • Always do an abdominal examination to assess for hepatosplenomegaly
      • Management:
        • Suction! Suction! Suction!
        • CXR unnecessary unless concern for superinfection or clinical picture not consistent with typical bronchiolitis (prolonged symptoms, high fevers, persistent hypoxia) à atelectasis and peribronchial cuffing on CXR if obtained
        • Viral testing is not always necessary (exception: influenza, COVID-19, RSV <1 month causes apnea)
        • Respiratory support
        • Dexamethasone in patients <1yo with no history of wheezing did not demonstrate benefit
        • Albuterol has not been shown to benefit patients
      • Bronchiolitis Score is helpful with risk stratification
      • Discharge Criteria
        • O2 saturation >90% while awake
        • Adequate PO intake
        • Mild/moderate work of breathing
        • Reliable caretaker
        • Timely pediatrician follow-up in 1-2 days
      • Admission Criteria
        • Hypoxemia
        • Severe respiratory distress
        • Apnea
        • High-risk patients
        • Poor oral intake
        • Parents uncomfortable with discharge
      • Consider intubation if…
        • Recurrent apnea
        • Declining mental status
        • Not improving with respiratory support
    • Asthma Exacerbation    
      • Antibody binds antigen à release of histamine/leukotrienes à inflammation à bronchospasm
      • Pediatric Respiratory Assessment Measure (PRAM) is helpful for risk stratification
      • Timing of medications is key!
      • CXR is not required unless concern for complicating factors
      • Management:
        • Beta-2 agonists 
          • Albuterol à MDI vs. nebulizer
            • Always use a spacer!
            • Short vs. 1-hour long vs. continuous albuterol nebulizer
            • Discharge à take 4 puffs every 4 hours for the next 48 hours, then as needed after that
            • Remember to write for MDI with spacer if discharging with albuterol prescription
          • Terbutaline à IV vs. SQ
        • Corticosteroids à mainstay of treatment considering the pathophysiology
          • Dexamethasone
          • Prednisone/prednisolone
          • Methylprednisolone
        • Ipratropium nebulizer
          • Anticholinergic
          • Often used in conjunction with albuterol nebulizer
        • Magnesium sulfate
          • Smooth-muscle relaxer
          • Can cause smooth-muscle relaxation in the vasculature à hypotension (consider IVF bolus)
        • Epinephrine à anaphylaxis dosing
      • Admission Criteria
        • Requiring >1 1-hour long albuterol
        • Respiratory distress
        • Hypoxemia (O2 <92%)
        • Dehydration
    • Croup (laryngotracheobronchitis à upper airway)
      • Acute subglottic inflammation
        • Morbidity is greatest in 1st year of life due to narrower subglottic airway
      • Affects children aged 6-36 months
      • Classically caused by parainfluenza virus, but also caused by many other viruses
      • Clinical presentation:
        • Barky cough
        • Inspiratory stridor (more concerning if occurring at rest)
        • Tachypnea
        • Suprasternal retractions (hypoxia, intercostal retractions, abnormal breath sounds, subcostal retractions are uncommon à croup is a disease of the upper airway, if hypoxia is present and lungs are clear to auscultation there should be high concern for impending upper airway compromise)
        • Low-grade fever
      • Management
        • Dexamethasone
        • Racemic epinephrine for resting stridor or respiratory distress (can repeat every 15-20 minutes)
        • Monitor for 3-4 hours prior to discharge if administering racemic epinephrine à admit for refractory stridor or if repeat dosing of racemic epinephrine is required
        • Consider Heliox for severe respiratory distress as it decreases turbulent flow
  • Documentation Lecture (Ashley Chesman)
    • Critical Care Documentation
      • 7.2% of all ED visits reported to Medicare in 2019 were reported as critical care
      • Time at bedside, but also time spent engaged in work directly related to the patient’s care:
        • Reviewing test results and imaging studies
        • Consulting services
        • Placing orders
      • Procedures billed separately
      • Billings starts at 30 minutes à critical care time requests <30 minutes may not be compensated  
      • E/M and Critical Care Same Date of Service
        • Can now bill for E/M and Critical Care on the same date/visit
        • Documentation must support decompensation to a state requiring critical care
      • Remember to document critical care time beginning in residency!
  • Subclavian Central Venous Lines (Drs. Nichols and Leavitt)
    • Contraindications
      • Overlying infection
      • Anatomic obstruction
      • Fracture of ipsilateral clavicle
      • Relative à coagulopathy (harder to compress and apply pressure to the subclavian site)
    • Complications
      • Arterial injury
      • Pneumothorax
      • Air embolism
      • Cardiac dysrhythmia
      • Infection
      • Bleeding
    • Supra- vs. Infraclavicular Subclavian Access
      • Infraclavicular
        • Utilizes short-axis ultrasound
        • Index finger on the sternal notch and thumb at the midpoint of the clavicle at the angle
        • Make contact with the clavicle and “walk-down” and pass under the clavicle vs. insert needle further laterally to avoid having to “walk-down” the clavicle
        • Ultrasound assisted technique utilizes short-axis
      • Supraclavicular
        • Well-defined landmarks (claviculo-SCM angle)
          • 1 cm superior and 1 cm lateral to the claviculo-SCM angle
          • 5-15 degrees above the coronal plane
          • Don’t advance past 3 cm
          • Ultrasound assisted technique utilizes long-axis as opposed to the short-axes
        • Shorter distance from skin to vein
        • Larger target area
        • Straighter path to the SVC
        • Less proximity to the lung
        • Fewer complications compared to infraclavicular
        • Found to be non-inferior to the infraclavicular approach

Conference 04/06/2022

04/06/2022

  • Lightning Lectures – Pulmonary Cases (Drs. Bishop and Slaven)
    • Tuberculosis
      • TB concern à NAAT + sputum cultures to assist with diagnosis (95% sensitive)
        • Negative pressure room with airborne precautions, PPE precautions for providers, HIV test if TB suspected  
      • Mycobacterium tuberculosis à aerobic rod, highly antigenic à can disseminate systemically if initial granuloma formation fails to contain the infection
      • Immunocompromised population at highest risk (2x)
      • bCG vaccine recipients all have positive TB skin tests (PPD)
      • Interferon test does not distinguish between latent and active TB
      • Active TB àINH, RIF, pyrizanimide, ethambutol x8 weeks à INH/RIF x18 weeks + B6
        • Hepatotoxicity
      • Latent TB à INH x9 months + B6
      • Must contact Public Health Department prior to discharge
    • Spontaneous Pneumothorax
      • Sudden pleuritic chest pain, increased work of breathing, hypoxia
      • DDx with examination + upright CXR
        • CT chest is very sensitive/specific but takes time to obtain
        • Consider US
      • Management:
        • Supplemental O2
        • Unstable à Decompression (treatment for tension PTX)
        • Stable, small à consider observation 4-6 hours, repeat CXR, must ensure follow-up within 24 hours à admit any recurrent or complicated PTX
        • Admit everything else and all PTX caused by comorbidities
  • Inhaled Intoxicants (Dr. Eisenstat)
    • Huffing/bagging à toluene is intoxicating substance (higher in gold and silver paints)
      • Can cause NAGMA, renal tubular acidosis, hypokalemia, chronic encephalopathy
      • Sudden sniffing death syndrome à hydrocarbon (huffing) + high levels of catecholamine surge à death
        • Generally not recommended to use epinephrine/norepinephrine in patients suspected of hydrocarbon toxicity
    • Aluminum encephalopathy from black tar heroin use à basal ganglia lesions on MRI
    • High water solubility à chlorine, tear gases, ammonia (mucous membrane effects)
    • Low water solubility à phosgene, chloramine, nitrogen dioxide (delayed pulmonary edema)
    • Phosphine gas/aluminum phosphide à occurs when aluminum phosphide interacts with moisture à can expose providers during ventilation efforts/resuscitation
    • Nitrogen dioxide à silo fillers
    • Phosgene à choking agent, delayed pulmonary edema
    • Tear gases à OC spray AKA pepper spray AKA mace à capsaicin-based tear gas à causes severe burning and irritation, CS (military grade) is more potent
      • Treatment is irritation (consider Morgan lens for eye involvement)
    • Organophosphates à nerve agents àdecontamination, atropine, pralidoxime, supportive care
    • Asphyxiants à methane, propane, argon gas à sudden collapse, helper also collapses, etc.
    • Carbon monoxide à can be high in smokers (COHgb of 10) and large cities
      • Treatment is controversial à begins with O2 therapy (100% FiO2, NRBM)
      • Consider hyperbaric in COHgb levels >25 (15 in pregnant patients due to fetal Hgb affinity for CO) or signs of organ dysfunction (AMS, NSTEMI)
      • The reason for HBO therapy is to reduce long-term symptoms, which are often delayed (up to 6-8 weeks), not life-saving
    • Cyanide à combustion of nitriles in house fires à leads to unconsciousness and CV collapse à elevated lactate (>8 with ingestion, >10 in house fires) with high suspicion
      • Amyl nitrite (induces methemoglobinemia) vs. Hydroxocobalamin/Cyanokit (safer, colors urine organe/red) with levels >8 
    • Hydrogen sulfide à cellular asphyxiant similar to cyanide à rotten-egg smell in low concentrations (odorless in high concentrations), used in chemical suicide
  • COPD and Asthma Cases (Dr. French)
    • COPD à titrate goal O2 to 88-92%
    • Patients need PPV
    • Antibiotics for COPD exacerbation à some evidence for reduced rate of readmission/representation
    • Remember to consider breath-stacking/auto-PEEP in MV
    • PRAM Score for asthma exacerbation à follow-up 3 hours with additional PRAM Score, can assist with disposition planning
      • PRAM >12 à marker of impending respiratory failure
  • ED Management of Brain Aneurisms (Dr. Ding)
    • Unstable à repair
    • Stable à timely outpatient follow-up
    • 1/3 will die, 1/3 will be self-sufficient at discharge, 1/3 will have poor recovery
    • Surgery (clip) vs. endovascular (coiling)
      • Treatment modality depends on multiple factors à age, medical comorbidities, multiple aneurisms, location, size, symptoms
    • Which aneurisms will rupture à location (anterior communicating, posterior communicating aa. higher risk) vs. size of aneurism vs. risk factors vs. family history vs. connective tissue disease/AAA vs. stress vs. growth of aneurism  
    • Enlarging and symptomatic unruptured aneurisms should be treated
    • Before/after stent-coiling or flow diversion à DAPT
    • Consult NES for incidentally found aneurisms on imaging, both admitted and discharged
    • CTA/MRA for history of aneurism and symptoms
    • Consider SAH in post-coital headache 
    • Don’t forget about LP vs. MRI in patients suspicious for SAH with negative CT/CTA

Small-bore Catheter (6-12 F) Thoracostomy Tube Placement

Small-bore Catheter (6-12 F) Thoracostomy Tube Placement

Small-bore catheter kit includes:

  • Small-bore catheter (6-12 F)
  • Trocar
  • Finder needle with syringe
  • Guide wire
  • Heimlich flutter valve (one-directional)
  • 11-blade scalpel
  • Local anesthetic with additional needle and syringe
  • Sterile drapes
  • Sterilizing solution

Indications:

  • Pneumothorax (especially stable, non-traumatic, spontaneous pneumothorax)
  • Pleural effusion drainage in the unstable patient
    • Large-bore chest tubes are still recommended for more viscous effusions such as empyema or hemothorax  

Step-by-step Guide:

  1. Prepare the chest tube atrium and ensure appropriate length tubing is available for low wall suctioning once the procedure is complete
  2. Place the patient in either a lateral recumbent or supine body position with the head of the bed elevated to 30-45 degrees, or in a seated position with the patient leaning slightly forward for posterior tube placement (i.e. tube placement for drainage of pleural effusions, ultrasound guidance is recommended for posterior tube placement similar to with thoracentesis both to identify the location of the effusion and due to the increased presence of vascular structures between the rib spaces posteriorly)
  3. Identify the location of insertion, usually the 4-5th intercostal space at the mid-axillary line (similar to large-bore chest tube placement) at the level of the nipple. Remember the “safety triangle” bordered by the lateral edges of the pectoralis and latissimus dorsi muscles where there is a decreased risk for damage to underlying vascular, nervous, and organ structures
  4. Sterilize the skin surrounding the site of insertion and drape the patient accordingly using the drape provided in the kit, or by using sterile towels if preferred (remember to leave the nipple exposed to assist with identifying landmarks during catheter placement)
  5. Measure the small-bore catheter in front of the patient’s chest to determine the appropriate depth of insertion in a manner which ensures placement towards to superior aspect of the chest with all side ports within the pleural cavity (remember, the catheter can be withdrawn but not inserted further once the procedure is complete, similar to placing a central venous catheter)
  6. Generously anesthetize the skin at the desired site of insertion, advancing your needle deeper over the superior aspect of the rib to minimize the risk of damage to the neurovascular bundle, withdrawing prior to injecting lidocaine as the needle progresses through the soft tissue. Be sure to anesthetize the parietal pleural during this process, as it is fine for the needle tip to pass into the chest cavity
  7. Gently advance the finder needle over the superior aspect of the rib through the intercostal musculature similarly to the previous step while steadily drawing back against the syringe plunger as the needle tip advances. The plunger pressure will give way once access into the pleural cavity is achieved. Consider loading the finder needle syringe with several mL of sterile water for visualization of air bubbles in the syringe to assist with this step
  8. Once access to the pleural space has been achieved remove the syringe from the finder needle and insert the guide wire into the back of the finder needle passing the wire into the pleural cavity in such a manner that leaves most of the wire hanging outside of the patient
  9. Remove the needle from the patient and make a small incision in the skin at the base of the guide wire using the provided 11-blade scalpel
  10. Pass the dilator over the guidewire and into the pleural space feeling it give-way once it has pierced the parietal pleura and entered the thoracic cavity. Be sure to visualize the guide wire exiting the back of the dilator prior to insertion to ensure the wire is not accidentally lost within the chest. The dilator may be removed once this step is complete
  11.  Pass the small-bore catheter within its trocar over the guide wire and into the pleural space in a manner that ensures all side ports are within the space. Generally, the first black indicator line can be used for small and thin patients, the second black line for the average adult, and the third black line for large adults. Similarly to the above step, ensure the guide wire is visualized exiting the back of the trocar prior to insertion.

HD – Pigtail Chest Tube Insertion | EM:RAP (emrap.org)